The relative bioavailability of hydrocodone from NORCO when compared with extended-release hydrocodone products and solutions is not known, so conversion to extended-launch products and solutions must be accompanied by near observation for indications of abnormal sedation and respiratory depression. Parenteral drug abuse is usually affiliated with transmission of infectious disorders https://nonprescriptionsmedsonline.com/product-category/baby-formula/